Albert Saporta
Presidente en Stallergenes Ibérica SA .
Cargos activos de Albert Saporta
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Stallergenes Ibérica SA | Presidente | 26/07/2010 | - |
Alergovet SA | Director/Miembro de la Junta | 26/07/2010 | - |
Stallergènes Sp zoo | Director/Miembro de la Junta | 01/01/2011 | - |
Presidente | 01/01/2011 | 01/01/2011 | |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The company has a deep understanding of allergens and is committed to innovation. | Director/Miembro de la Junta | 01/01/2009 | - |
Stallergenes, Inc. | Director/Miembro de la Junta | 01/01/2011 | - |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Director/Miembro de la Junta | - | - |
Presidente | - | - | |
ASAP France SARL | Presidente | - | - |
Historial de carrera de Albert Saporta
Antiguos cargos conocidos de Albert Saporta.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ATON | Director/Miembro de la Junta | 11/12/2012 | 14/10/2019 |
Independent Dir/Board Member | 11/12/2012 | 14/10/2019 | |
STALLERGENES | Director/Miembro de la Junta | 21/09/2012 | 27/05/2014 |
Presidente | 26/07/2010 | 21/09/2012 | |
Presidente | 26/07/2010 | 13/01/2012 | |
░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░ ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Estadísticas
Internacional
Francia | 8 |
Suiza | 3 |
España | 2 |
Operativa
Director/Board Member | 7 |
Chairman | 6 |
President | 2 |
Sectorial
Health Technology | 7 |
Distribution Services | 3 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ATON | Health Technology |
Empresas privadas | 14 |
---|---|
Alternative Investment Management & Research SA
Alternative Investment Management & Research SA Alternative Investment Management & Research SA (AIM&R) is an alternative research and investment management firm which was founded in 1995 by Albert Saporta. Located in Geneva, Switzerland, AIM&R manages the S.O.G. Fund and SOGAsia hedge funds and managed accounts for sophisticated investors. In 2003 the firm formed a strategic alliance with United Overseas Bank Ltd., Singapore, through their subsidiary UOB Global Capital LLC, for the exclusive worldwide distribution of the SOGAsia Fund. AIM&R also advises hedge funds and trading groups. | |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Stallergenes Ibérica SA | Distribution Services |
Alergovet SA | |
Stallergenes Belgium SA
Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium. | Health Technology |
Stallergenes AG
Stallergenes AG Pharmaceuticals: OtherHealth Technology Stallergenes AG engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields. It specializes in the production of allergen extracts for allergen immunotherapy. The firm also offers tools for the diagnosis of allergies. The company was founded on October 28, 1996 and is headquartered in Dietlikon, Switzerland. | Health Technology |
Stallergènes Sp zoo | |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The company has a deep understanding of allergens and is committed to innovation. | Distribution Services |
Stallergenes, Inc. | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Health Services |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
Pasteur Merieux Serums et Vaccins SA | Health Technology |
Pasteur Mérieux Connaught | |
ASAP France SARL |
- Bolsa de valores
- Insiders
- Albert Saporta
- Experiencia